Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
02.06.19 | ERLEADA?(Apalutamid) sorgt für signifikant verlängertes Gesamtüberleben und radiographisches progressionsfreies Überleben bei Patienten mit hormonresistentem metastasiertem Prostatakarzinom | 462 | Business Wire | Präsentation der Ergebnisse der Phase-3-Studie in einem mündlichen Vortrag auf dem ASCO 2019,für die "Best of ASCO 2019 Meetings" vorgeschlagen und gleichzeitig veröffentlicht im The New... ► Artikel lesen | |
02.06.19 | Study Investigating Darzalex? (daratumumab) Shows Improved Depth of Response and Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who are Eligible for a Transplant | 298 | Business Wire | Pivotal Phase 3 data presented in ASCO oral session and simultaneously published in The Lancet The Phase 3 CASSIOPEIA study is one of the largest transplant studies ever conducted in... ► Artikel lesen | |
02.06.19 | Phase 3 COLUMBA Study Investigating a Subcutaneous Formulation of Darzalex? (daratumumab) Showed Non-Inferiority to Intravenous Administration in Patients with Relapsed/Refractory Multiple Myeloma | 326 | Business Wire | Subcutaneous formulation also showed reduced administration time and lower rates of infusion-related reactions compared to intravenous administration The Janssen Pharmaceutical Companies... ► Artikel lesen | |
02.06.19 | Die COMPUTEX 2019 geht erfolgreich zu Ende | 266 | Business Wire | Der Kampfgeist im Bereich Gaming weitert sich auf den Wettbewerb beim High-Performance-Computing aus Die COMPUTEX 2019 wurde heute (am 1. Juni) mit großem Erfolg abgeschlossen. In... ► Artikel lesen | |
02.06.19 | BAE Systems Partners with UiPath to Expedite Machine Learning Adoption across the U.S. Defense and Intelligence Communities | 625 | Business Wire | BAE Systems is a technology partner with robotic process automation (RPA) leader, UiPath, in developing suites of software robots that its customers can use to automate high-volume, repetitive... ► Artikel lesen | |
02.06.19 | SOTIO's DCVAC/LuCa Significantly Improves Survival in Patients with Stage IV Non-small Cell Lung Cancer | 311 | Business Wire | DCVAC/LuCa decreased the risk of death in patients with stage IV NSCLC by 46% Median overall survival (OS) reached 15.5 months in the treatment arm compared to 11.8 months in... ► Artikel lesen | |
02.06.19 | Pivotal Phase 3 ARTEMIS Trial Data Demonstrates Consistent Safety and Efficacy of AR101 in Children and Adolescents with Peanut Allergy | 311 | Business Wire | Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today presented topline results from the pivotal European... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 2.831 |
NEL | 1.637 |
APPLE | 1.521 |
BAYER | 1.490 |
BYD | 1.478 |
SUPER MICRO COMPUTER | 1.356 |
DEUTSCHE BANK | 1.241 |
NVIDIA | 1.219 |
TUI | 1.219 |
PLUG POWER | 1.075 |
TESLA | 1.026 |
DAIMLER TRUCK | 935 |
MERCEDES-BENZ | 913 |
RHEINMETALL | 895 |
RWE | 891 |
AURUBIS | 806 |
RENK GROUP | 782 |
DEUTSCHE LUFTHANSA | 781 |
COMMERZBANK | 761 |
VOLKSWAGEN | 759 |
AMAZON | 752 |
SIEMENS ENERGY | 692 |
AIXTRON SE | 669 |
SIXT SE VZ | 651 |
ALLIANZ | 617 |